View source for 18F-FDG

'''18F-FDG''' (pronounced "eighteen F-F-D-G"), also known as '''[[Fluorodeoxyglucose (18F)]]''', is a radiopharmaceutical used in the medical imaging modality [[Positron Emission Tomography]] (PET). 

==Etymology==
The term "18F-FDG" is an abbreviation for Fluorine-18 Fluorodeoxyglucose. The "18F" refers to the [[Fluorine-18]] isotope, and "FDG" stands for Fluorodeoxyglucose, a glucose analog.

==Usage==
18F-FDG is used as a tracer in [[PET scan|PET scans]] to detect abnormalities in glucose metabolism, which is often a sign of disease. It is commonly used in the diagnosis and monitoring of [[Cancer|cancer]], [[Cardiology|cardiology]], and [[Neurology|neurology]] conditions.

==Production==
18F-FDG is produced by substituting the hydroxyl group of glucose with [[Fluorine-18]], a radioactive isotope of fluorine. This process is carried out in a [[Cyclotron]], a type of particle accelerator.

==Related Terms==
* [[Radiopharmaceutical]]
* [[Positron Emission Tomography]]
* [[Fluorine-18]]
* [[Cyclotron]]
* [[Glucose]]

[[Category:Medical Imaging]]
[[Category:Radiopharmaceuticals]]
[[Category:PET Scan]]

{{stub}}